N NVO

Novo Nordisk

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Novo Nordisk A/S (NVO) is a leading global healthcare company based in Bagsvaerd, Denmark, with a primary focus on diabetes care, obesity management, and hormone replacement therapies. Renowned for its commitment to innovation and research, Novo Nordisk utilizes advanced biotechnology to develop hig...

$47.42

-2.13% ($1.03)

Volume 12.29M

52W High $91.34

52W Low $39.34

Market Cap $285.37B

← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data

Consensus EPS

$5.05

Whisper EPS

$5.23

3.5% above consensus

Last Quarter

$6.04

Current Streak

2 Beats

Avg Surprise (4Q)

+2.61%

Next Earnings Report

Reports in 70 days

Report Date May 6, 2026

Whisper Spread +3.50%

Consensus Estimate

$5.05

Official analyst average

Whisper Number

$5.23

What traders expect

Bullish Sentiment: The whisper number is 3.5% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Feb 3, 2026

1-Day: -6.18%

Q3 2025 Nov 5, 2025

1-Day: -4.02%

5-Day: -5.20%

Q2 2025 Aug 6, 2025

1-Day: +7.45%

5-Day: +9.89%

Q1 2025 May 7, 2025

1-Day: -4.00%

5-Day: +0.28%

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q4 2025	Feb 3, 2026	$5.90	$6.11	$6.04	+2.37%	Missed
Q3 2025	Nov 5, 2025	$4.24	$4.41	$4.50	+6.13%	Beat
Q2 2025	Aug 6, 2025	$6.00	$6.19	$5.96	-0.67%	Missed
Q1 2025	May 7, 2025	$6.07	$6.27	$6.53	+7.58%	Beat
Q4 2024	Feb 4, 2025	$6.12	$6.36	$6.34	+3.59%	Met
Q3 2024	Nov 6, 2024	$5.92	$6.11	$6.12	+3.38%	Met
Q2 2024	Aug 7, 2024	$0.74	$0.78	$0.66	-10.40%	Missed
Q1 2024	May 2, 2024	$0.77	$0.80	$0.83	+7.79%	Beat
Q4 2023	Jan 31, 2024	$0.66	$0.67	$0.71	+7.58%	Beat
Q3 2023	Nov 2, 2023	$0.69	$0.71	$0.73	+5.80%	Beat
Q2 2023	Aug 10, 2023	$0.63	$0.64	$0.67	+6.35%	Beat
Q1 2023	May 4, 2023	$0.61	$0.63	$0.63	+3.28%	Met